
Insiders Updates
BofA Securities gives an Underperform recommendation for Neumora Therapeutics Inc (NMRA)
Neumora Therapeutics Inc’s recent filing unveils that its Officer Henry Gosebruch acquired Company’s shares for reported $21450.0 on Mar 12